Two-Year Follow-Up and Remodeling Kinetics of ChonDux Hydrogel for Full-Thickness Cartilage Defect Repair in the Knee

Matthew T. Wolf, Hong Zhang, Blanka Sharma, Norman A. Marcus, Uwe Pietzner, Stefan Fickert, Achim Lueth, G. H.Robert Albers, Jennifer H. Elisseeff

Research output: Contribution to journalArticle

Abstract

Objective: To determine performance and repair kinetics of the ChonDux hydrogel scaffold for treating focal articular cartilage defects in the knee over 24 months. Design: This assessor-blinded trial evaluates ChonDux hydrogel scaffold implantation in combination with microfracture in 18 patients across 6 sites. Male and female patients 18 to 65 years of age with full-thickness femoral condyle defects 2 to 4 cm2 in area were enrolled. Eligible patients received ChonDux treatment followed by rehabilitation. Defect volume fill was evaluated after 3, 6 (primary outcome), 12, 18, and 24 months by assessor blinded magnetic resonance imaging (MRI) analysis. Secondary outcomes were T2-weighted MRI relaxation time and patient surveys via visual analogue scale (VAS) pain and International Knee Documentation Committee (IKDC) knee function scoring. Results: ChonDux maintained durable tissue restoration over 24 months with final defect percent fill of 94.2% ± 16.3% and no significant loss of fill volume at any time points. Tissues treated with ChonDux maintained T2 relaxation times similar to uninjured cartilage between 12 and 24 months. VAS pain scoring decreased between 1 and 6 weeks, and IKDC knee function scores improved by approximately 30.1 with ChonDux over 24 months. Conclusion: ChonDux treatment is a safe adjunct to microfracture therapy and promotes stable restoration of full thickness articular cartilage defects for at least 24 months.

Original languageEnglish (US)
JournalCartilage
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Hydrogel
Cartilage
Hydrogels
Knee
Repair
Defects
Kinetics
Stress Fractures
Articular Cartilage
Pain Measurement
Magnetic resonance
Scaffolds
Documentation
Relaxation time
Restoration
Magnetic Resonance Imaging
Tissue
Imaging techniques
Thigh
Patient rehabilitation

Keywords

  • biomaterials
  • cartilage repair
  • microfracture
  • scaffold
  • tissue engineering

ASJC Scopus subject areas

  • Immunology and Allergy
  • Biomedical Engineering
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Two-Year Follow-Up and Remodeling Kinetics of ChonDux Hydrogel for Full-Thickness Cartilage Defect Repair in the Knee. / Wolf, Matthew T.; Zhang, Hong; Sharma, Blanka; Marcus, Norman A.; Pietzner, Uwe; Fickert, Stefan; Lueth, Achim; Albers, G. H.Robert; Elisseeff, Jennifer H.

In: Cartilage, 01.01.2018.

Research output: Contribution to journalArticle

Wolf, Matthew T. ; Zhang, Hong ; Sharma, Blanka ; Marcus, Norman A. ; Pietzner, Uwe ; Fickert, Stefan ; Lueth, Achim ; Albers, G. H.Robert ; Elisseeff, Jennifer H. / Two-Year Follow-Up and Remodeling Kinetics of ChonDux Hydrogel for Full-Thickness Cartilage Defect Repair in the Knee. In: Cartilage. 2018.
@article{be0ff6ab5aa947b2999ae9b1db9a7095,
title = "Two-Year Follow-Up and Remodeling Kinetics of ChonDux Hydrogel for Full-Thickness Cartilage Defect Repair in the Knee",
abstract = "Objective: To determine performance and repair kinetics of the ChonDux hydrogel scaffold for treating focal articular cartilage defects in the knee over 24 months. Design: This assessor-blinded trial evaluates ChonDux hydrogel scaffold implantation in combination with microfracture in 18 patients across 6 sites. Male and female patients 18 to 65 years of age with full-thickness femoral condyle defects 2 to 4 cm2 in area were enrolled. Eligible patients received ChonDux treatment followed by rehabilitation. Defect volume fill was evaluated after 3, 6 (primary outcome), 12, 18, and 24 months by assessor blinded magnetic resonance imaging (MRI) analysis. Secondary outcomes were T2-weighted MRI relaxation time and patient surveys via visual analogue scale (VAS) pain and International Knee Documentation Committee (IKDC) knee function scoring. Results: ChonDux maintained durable tissue restoration over 24 months with final defect percent fill of 94.2{\%} ± 16.3{\%} and no significant loss of fill volume at any time points. Tissues treated with ChonDux maintained T2 relaxation times similar to uninjured cartilage between 12 and 24 months. VAS pain scoring decreased between 1 and 6 weeks, and IKDC knee function scores improved by approximately 30.1 with ChonDux over 24 months. Conclusion: ChonDux treatment is a safe adjunct to microfracture therapy and promotes stable restoration of full thickness articular cartilage defects for at least 24 months.",
keywords = "biomaterials, cartilage repair, microfracture, scaffold, tissue engineering",
author = "Wolf, {Matthew T.} and Hong Zhang and Blanka Sharma and Marcus, {Norman A.} and Uwe Pietzner and Stefan Fickert and Achim Lueth and Albers, {G. H.Robert} and Elisseeff, {Jennifer H.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/1947603518800547",
language = "English (US)",
journal = "Cartilage",
issn = "1947-6035",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Two-Year Follow-Up and Remodeling Kinetics of ChonDux Hydrogel for Full-Thickness Cartilage Defect Repair in the Knee

AU - Wolf, Matthew T.

AU - Zhang, Hong

AU - Sharma, Blanka

AU - Marcus, Norman A.

AU - Pietzner, Uwe

AU - Fickert, Stefan

AU - Lueth, Achim

AU - Albers, G. H.Robert

AU - Elisseeff, Jennifer H.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: To determine performance and repair kinetics of the ChonDux hydrogel scaffold for treating focal articular cartilage defects in the knee over 24 months. Design: This assessor-blinded trial evaluates ChonDux hydrogel scaffold implantation in combination with microfracture in 18 patients across 6 sites. Male and female patients 18 to 65 years of age with full-thickness femoral condyle defects 2 to 4 cm2 in area were enrolled. Eligible patients received ChonDux treatment followed by rehabilitation. Defect volume fill was evaluated after 3, 6 (primary outcome), 12, 18, and 24 months by assessor blinded magnetic resonance imaging (MRI) analysis. Secondary outcomes were T2-weighted MRI relaxation time and patient surveys via visual analogue scale (VAS) pain and International Knee Documentation Committee (IKDC) knee function scoring. Results: ChonDux maintained durable tissue restoration over 24 months with final defect percent fill of 94.2% ± 16.3% and no significant loss of fill volume at any time points. Tissues treated with ChonDux maintained T2 relaxation times similar to uninjured cartilage between 12 and 24 months. VAS pain scoring decreased between 1 and 6 weeks, and IKDC knee function scores improved by approximately 30.1 with ChonDux over 24 months. Conclusion: ChonDux treatment is a safe adjunct to microfracture therapy and promotes stable restoration of full thickness articular cartilage defects for at least 24 months.

AB - Objective: To determine performance and repair kinetics of the ChonDux hydrogel scaffold for treating focal articular cartilage defects in the knee over 24 months. Design: This assessor-blinded trial evaluates ChonDux hydrogel scaffold implantation in combination with microfracture in 18 patients across 6 sites. Male and female patients 18 to 65 years of age with full-thickness femoral condyle defects 2 to 4 cm2 in area were enrolled. Eligible patients received ChonDux treatment followed by rehabilitation. Defect volume fill was evaluated after 3, 6 (primary outcome), 12, 18, and 24 months by assessor blinded magnetic resonance imaging (MRI) analysis. Secondary outcomes were T2-weighted MRI relaxation time and patient surveys via visual analogue scale (VAS) pain and International Knee Documentation Committee (IKDC) knee function scoring. Results: ChonDux maintained durable tissue restoration over 24 months with final defect percent fill of 94.2% ± 16.3% and no significant loss of fill volume at any time points. Tissues treated with ChonDux maintained T2 relaxation times similar to uninjured cartilage between 12 and 24 months. VAS pain scoring decreased between 1 and 6 weeks, and IKDC knee function scores improved by approximately 30.1 with ChonDux over 24 months. Conclusion: ChonDux treatment is a safe adjunct to microfracture therapy and promotes stable restoration of full thickness articular cartilage defects for at least 24 months.

KW - biomaterials

KW - cartilage repair

KW - microfracture

KW - scaffold

KW - tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85058933902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058933902&partnerID=8YFLogxK

U2 - 10.1177/1947603518800547

DO - 10.1177/1947603518800547

M3 - Article

C2 - 30280586

AN - SCOPUS:85058933902

JO - Cartilage

JF - Cartilage

SN - 1947-6035

ER -